statistiche ricercatore

DONADINI, MARCO PAOLO

Distribuzione geografica

Continente	#
NA - Nord America	6.420
EU - Europa	2.740
AS - Asia	2.115
SA - Sud America	238
AF - Africa	37
OC - Oceania	8
Continente sconosciuto - Info sul continente non disponibili	2
Totale	11.560

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	6.341
IT - Italia	1.371
SG - Singapore	687
CN - Cina	485
UA - Ucraina	372
HK - Hong Kong	280
VN - Vietnam	254
SE - Svezia	232
TR - Turchia	216
BR - Brasile	197
DE - Germania	174
IE - Irlanda	128
GB - Regno Unito	109
FR - Francia	102
FI - Finlandia	81
RU - Federazione Russa	75
IN - India	62
BD - Bangladesh	49
MX - Messico	40
CA - Canada	29
NL - Olanda	25
IQ - Iraq	17
ES - Italia	16
AR - Argentina	15
AT - Austria	15
PL - Polonia	14
JP - Giappone	12
NG - Nigeria	10
ZA - Sudafrica	9
AU - Australia	7
BE - Belgio	7
EC - Ecuador	7
CO - Colombia	6
TW - Taiwan	6
UZ - Uzbekistan	6
AE - Emirati Arabi Uniti	5
CL - Cile	5
AL - Albania	4
ID - Indonesia	4
MY - Malesia	4
PK - Pakistan	4
BO - Bolivia	3
CH - Svizzera	3
EG - Egitto	3
IL - Israele	3
JM - Giamaica	3
KE - Kenya	3
NP - Nepal	3
SA - Arabia Saudita	3
TH - Thailandia	3
TN - Tunisia	3
BA - Bosnia-Erzegovina	2
BG - Bulgaria	2
CI - Costa d'Avorio	2
CR - Costa Rica	2
ET - Etiopia	2
EU - Europa	2
JO - Giordania	2
KG - Kirghizistan	2
LB - Libano	2
LT - Lituania	2
MA - Marocco	2
PT - Portogallo	2
VE - Venezuela	2
AM - Armenia	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
GD - Grenada	1
GR - Grecia	1
GT - Guatemala	1
HN - Honduras	1
HR - Croazia	1
IR - Iran	1
KH - Cambogia	1
KZ - Kazakistan	1
LK - Sri Lanka	1
MU - Mauritius	1
NZ - Nuova Zelanda	1
PE - Perù	1
PH - Filippine	1
PY - Paraguay	1
TT - Trinidad e Tobago	1
TZ - Tanzania	1
UY - Uruguay	1
Totale	11.560

Salva come PNG Salva come JPEG

Città	#
Milan	898
Fairfield	799
Ashburn	506
Woodbridge	497
San Jose	432
Singapore	397
Houston	354
Seattle	323
Wilmington	283
Chandler	280
Hong Kong	276
Ann Arbor	270
Jacksonville	270
Cambridge	240
The Dalles	130
Izmir	126
Dublin	124
Princeton	123
Chicago	119
Dallas	119
Dearborn	92
Los Angeles	88
Council Bluffs	87
Nyköping	87
Beijing	86
Boardman	84
Rome	74
Dong Ket	70
Lauterbourg	69
San Diego	47
New York	46
Santa Clara	46
Ho Chi Minh City	39
London	36
Ogden	33
Hanoi	32
Mexico City	30
Salt Lake City	26
Guangzhou	24
Helsinki	24
Tampa	19
San Mateo	18
Afragola	17
Como	17
Elk Grove Village	17
Orem	17
São Paulo	16
Shanghai	15
Chennai	14
Denver	14
Frankfurt am Main	14
Varese	14
Hangzhou	13
San Francisco	12
Nuremberg	11
Schiffdorf	11
Brooklyn	10
Manchester	10
Warsaw	10
Abuja	9
Buffalo	9
Columbus	9
Düsseldorf	9
Falkenstein	9
Hefei	9
Montreal	9
Phoenix	9
Tokyo	9
Washington	9
Cavaria con Premezzo	8
Kunming	8
Miami	8
Nanjing	8
Ralingen	8
Amsterdam	7
Bangalore	7
Brussels	7
Dulles	7
Haiphong	7
Johannesburg	7
Lancaster	7
Munich	7
Nanchang	7
Olgiate Olona	7
Redmond	7
Shenzhen	7
Sterling	7
Stockholm	7
Tianjin	7
Verona	7
Baghdad	6
Belo Horizonte	6
Campinas	6
Jinan	6
Naples	6
Norwalk	6
Redwood City	6
Tashkent	6
Toronto	6
Atlanta	5
Totale	8.256

Salva come PNG Salva come JPEG

Nome	#
Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism: a Delphi analysis of experts	403
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis	306
Risk of recurrence of unusual site venous thromboembolism	257
Optimal treatment duration of venous thrombosis	251
Breadth of complications of long-term oral anticoagulant care	246
Novel oral anticoagulants for the prevention of venous thromboembolism in surgical patients	237
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data	232
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism	223
Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism.	222
Patient selection for thromboprophylaxis in medical inpatients	218
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree?	216
Prognostic stratification of chronic heart failure in elderly population: are cardiopulmonary tests and BNP really valuable?	210
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study	208
Treating patients with cancer and acute venous thromboembolism	202
Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation	200
Brain natriuretic peptide and preclinical chronic thromboembolic pulmonary hypertension.	197
An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis	190
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events	189
Antidotes for the direct oral anticoagulants: What news?	189
Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-Extension study).	188
Pulmonary Embolism in Medical-Surgical Critically Ill Patients	187
Certoparin for the treatment and prevention of thrombosis: pharmacological profile and results from clinical studies	184
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs	184
Aspirin plus clopidogrel vs aspirin alone for preventing cardiovascular events among patients at high risk for cardiovascular events	181
Age-adjusted D-dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm	179
Brand name versus generic warfarin: a systematic review of the literature.	175
Retrievable vena cava filters: a clinical review.	175
Splanchnic vein thrombosis: new risk factors and management	174
Clinical approach to splanchnic vein thrombosis: Risk factors and treatment.	174
Evaluation of right ventricular function in patients with a previous episode of pulmonary embolism using tissue Doppler imaging.	171
Should alcohol be considered a minor protective factor for unprovoked venous thromboembolism?	166
Efficacy and safety of dabigatran etexilate: a narrative review	165
Antiphospholipid Syndrome: A Challenging Hypercoagulable State with Systemic Manifestations	163
Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors	159
JAK inhibitors and psoriatic arthritis: A systematic review and meta-analysis	156
Prognostic clinical prediction rules to identify a low-risk pulmonary embolism: a systematic review and meta-analysis.	153
Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET)	149
Incidence of symptomatic and asymptomatic chronic pulmonary hypertension in patients with a previous episode of pulmonary embolism: a prospective cohort study	147
Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis	146
Which patients with unprovoked VTE should receive extended anticoagulation? the minority.	145
Expert-Based Narrative Review on Compression UltraSonography (CUS) for Diagnosis and Follow-Up of Deep Venous Thrombosis (DVT)	140
Combined warfarin-aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?	140
Trattamento del tromboembolismo venoso con anticoagulanti tradizionali e di nuova generazione.	139
The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury: a prospective cohort study.	132
Prediction scores do not correlate with clinically adjudicated categories of pulmonary embolism in critically ill patients	132
PROPOSAL FOR THE INCLUSION OF LOW MOLECULAR WEIGHT HEPARINS FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN HOSPITALIZED PATIENTS IN THE WHO MODEL LIST OF ESSENTIAL MEDICINES	131
Upper extremity deep vein thrombosis treated with direct oral anticoagulants: a multi-center real world experience	124
Venous thromboembolism: pathophysiology, diagnosis and prophylaxis	119
Drug–Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review	115
Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET)	112
Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation	112
null	109
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study.	99
Anticoagulant treatment for Upper Extremity Deep Vein thrombosis: a systematic review and meta-analysis	96
Management of bleeding in patients receiving conventional or new anticoagulants: a practical and case-based approach	93
Risk of Deep Vein Thrombosis Following a Single Negative Whole-Leg Compression Ultrasound A Systematic Review and Meta-analysis	93
Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism	90
Splanchnic vein thrombosis	90
Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants	88
Unusual site thrombosis.	87
Manuale di emergenze medico-chirurgiche	82
Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study	80
Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis	77
Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis	77
La trombosi venosa profonda e l’embolia polmonare	76
Initial and Long-Term Treatment of Pulmonary Embolism: Current Approach and Future Perspectives	75
Factor XI inhibitors for the prevention of cardiovascular disease: A new therapeutic approach on the horizon?	72
Current and emerging drug strategies for the prevention of venous thromboembolism in acutely ill medical inpatients	72
Perioperative Management of Patients who are Receiving Oral Anticoagulant Therapy	71
Development of personalized thrombogenesis and thrombin generation assays to assess endothelial dysfunction in cardiovascular diseases	67
Venous and arterial thromboembolic risk of Janus kinase inhibitors: a systematic review with meta-analysis	63
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study	61
Steps towards simplifying the treatment of pulmonary embolism	61
The Link Between Venous and Arterial Thrombosis: Is There a Role for Endothelial Dysfunction?	58
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?	57
Rates of venous thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital hemophilia A or B: a systematic review	57
Venous Thromboembolism Risk Associated with MIDLINE Catheters and Peripherally Inserted Central Catheters, a Systematic Review and Meta-Analysis	54
DOACs use in extreme body-weighted patients: results from the prospective START-register	51
Use of artificial intelligence and radiomics for risk stratification in patients with pulmonary embolism: New tools for an old problem	50
The Clinical Impact of the Pulmonary Embolism Severity Index on the Length of Hospital Stay of Patients with Pulmonary Embolism: A Randomized Controlled Trial	46
Drug–drug interactions between DAAs and anticoagulants or antiplatelets: a position paper of the italian anticoagulation clinics	45
Geographical and ethnoracial differences in venous thromboembolism and anticoagulation: An expanding horizon	42
Efficacy and safety of low-dose acetylsalicylic acid for the prevention of thromboembolic events in individuals positive for antiphospholipid antibodies: A systematic review and meta-analysis	40
More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study	32
Implementing anticoagulation stewardship: the use of a dedicated mobile phone ‘app’ in the experience of the Italian Federation of Anticoagulation linics (FCSA)	20
Distal deep vein thrombosis: is there a way out of this dark forest?	19
Thrombotic events after vaccination for covid-19 in Italy: a report from the Italian society on thrombosis and haemostasis registry	13
Results from an Expert-Based Cross-Sectional National Survey on Antithrombotic TREATment After PEDiatric Peripheral Vascular Injuries. (The TREAT-PED-PVI Survey)	9
Prescribing patterns and clinician preferences for direct oral anticoagulant use in unusual site venous thromboembolism: a cross-sectional analysis from the Direct oral anticoagulants in Unusual Site venous Thromboembolism (DUST) study	6
Exploring Italian nursing staff in anticoagulation clinics: a cluster-based description of current practice, nurse self-efficacy, job satisfaction, and interprofessional collaboration	2
Totale	11.693

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	46.982
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	46.982

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	758	98	116	21	36	58	36	33	50	43	123	64	80
2022/2023	760	78	64	28	96	57	158	10	84	123	26	19	17
2023/2024	1.432	244	234	227	274	278	60	2	26	60	8	18	1
2024/2025	1.380	8	12	187	18	19	89	58	90	90	107	297	405
2025/2026	3.061	231	141	142	304	214	230	562	220	410	246	167	194
2026/2027	55	55	0	0	0	0	0	0	0	0	0	0	0
Totale													11.693